Journal List > Perspect Nurs Sci > v.11(1) > 1060397

Lee and Kim: Relationships between Anxiety, Depression, Low Anterior Resection Syndrome, and Quality of Life Following Lower Anterior Resection for Rectal Cancer

Abstract

Purpose

The purpose of this study wastoinvestigatethe relationshipsbetweenanxiety, depression, low anterior resection syndrome, and qualityof life after lower anterior resectionfor rectal cancer.

Methods

Theparticipants ofthisstudy were 105 rectal cancer patientswho visitedtheoutpatient departmentof a hospitalin Seoulfor treatment or follow-up consultations. Data were collected using self-reportedquestionnaires and clinical records. To measurethevariables, theHospital AnxietyandDepressionScale, Low Anterior ResectionSyndromeScore, and Qualityof LifeQuestionnaire-Core 30wereutilized. Dataweresubsequently analyzed usingtheSPSS/WIN 20.0 program.

Results

Low anterior resectionsyndromewas more severeamong patientswhose cancer was located closerto theanus, and had agreater rangeof resectioninthosewhoreceivedneoadjuvant treatment. Whenanxi-ety, depression, and low anterior resection syndrome score were higher, quality of life scores were lower.

Conclusion

These results suggest that low anterior resection syndrome may negatively impact quality of life. Therefore, it is necessary to provide patients with symptom management support/assistance through evidence-basednursinginterventions, andevaluations oflow anterior resection syndrometo relieveanxietyandde-pression, and thus enhance quality of life.

References

1. Cancer Registration Statistics [Internet]. Seoul: National Statistical Office;; [cited 2013 Jun 1]. Availabefrom:. http://kosis.kr/statisticsList/statisticsList_01List.jsp?vwcd=MT_ZTITLE&parentId=A#SubCont.
2. Jhealthmedia.joins.com [Internet]. Seoul: JoongAng Ilbo Health Media;c2011. [updated 2011 Sep 2; cited 2013 May 7]. Available from:. http://jhealthmedia.joins.com/news/article-View.html?idxno=1641.
3. Kim JW.The qualityof lifeafter rectal cancersurgery.Korean J Gastroenterol. 2006 Apr. 47(4):295–9.
4. National Comprehensive Cancer Network. NCCN Guidelines for Patients: Colon and Rectal Cancer [Internet]. Washington: National Comprehensive Cancer Network;2012. January [cite d 2013 May 7]. Available from:. http://www.nccn.org/patients/guidelines/colon/index.html.
5. Maris A, Penninckx F, Devreese AM, Staes F, Moons P, Van Cutsem E, et al. Persisting anorectal dysfunction after rectal cancer surgery. Colorectal Dis. 2013; 15(11):e672–9. http://dx.doi.org/10.1111/codi.12291.
crossref
6. Cotrim H, Pereira G. Impact of colorectal cancer on patient and family: implications for care. Eur J Oncol Nurs. 2008; 12(3):217–26. http://dx.doi.org/10.1016/j.ejon.2007.11.005.
crossref
7. Cancer Research UK. Cancer Report: Bowel cancer treatment [Internet]. London: Cancer Research UK;; [Updated 2013 Aug 28; cited 2013 Jul 20]. Availablefrom:. http://www.cancerresearchuk.org/cancer-help/type/bowel-cancer/treatment/surgery/which-surgery-for-bowel-cancer.
8. Bregendahl S, Emmertsen KJ, Lous J, Laurberg S. Bowel dysfunction after low anterior resection with and without neoadjuvant therapy for rectal cancer: a population-based cross-sectional study. Colorectal Dis. 2013; 15(9):1130–9. http://dx.doi.org/10.1111/codi.12244.
crossref
9. Scheer AS, Boushey RP, Liang S, Doucette S, O'Connor AM, Moher D. The longterm gastrointestinal functional outcomes following curative anterior resection inadults withrectal cancer: a systematic reviewand metaanalysis. Dis ColonRectum. 2011; 54(12):1589–97. http://dx.doi.org/10.1097/DCR.0b013e3182214f11.
10. Brown SR, Seow-Choen F. Preservation of rectal function after low anterior resection with formation of a neorectum. Semin Surg Oncol. 2000; 19(4):376–85. http://dx.doi.org/10.1002/ssu.8.
crossref
11. Bryant CL, Lunniss PJ, Knowles CH, Thaha MA, Chan CL. Anterior resection syndrome. Lancet Oncol. 2012; 13(9):e403–8. http://dx.doi.org/10.1016/S1470–2045(12)70236-X.
crossref
12. Kim HK. A prospective study on functional derangements and quality of life after sphincter saving resection in patients with rectal cancer [master's thesis]. Ulsan: Ulsan University;2006.
13. Kakodkar R, Gupta S, Nundy S. Low anterior resection with total mesorectal excision for rectal cancer: functional assessment and factors affecting outcome. Colorectal Dis. 2006; 8(8):650–6. http://dx.doi.org/10.1111/j.1463–1318.2006.00992.x.
crossref
14. Debus ES, Sailer M, Fuchs KH, Thiede A. [Pouch reconstruction after resection of the rectum]. Zentralbl Chir. 2001; 126(Suppl 1):60–3. http://dx.doi.org/10.1055/s-2001–19202.
15. Gross E, Moslein G. [Colonic pouch and other procedures to improve the continence after low anterior rectal resection with TME]. Zentralbl Chir. 2008; 133(2):107–15. http://dx.doi.org/10.1055/s-2008–1004735.
16. Andersson J, Angenete E, Gellerstedt M, Angeras U, Jess P, Rosenberg J, et al. Health-related quality of life after laparoscopic and open surgery for rectal cancer in a randomized trial. Br J Surg. 2013; 100(7):941–9. http://dx.doi.org/10.1002/bjs.9144.
crossref
17. Bennis M, Parc Y, Lefevre JH, Chafai N, Attal E, Tiret E. Morbidity risk factors after low anterior resection with total mesorectal excision and coloanal anastomosis: a retrospective series of 483 patients. Ann Surg. 2012; 255(3):504–10. http://dx.doi.org/10.1097/SLA.0b013e31824485c4.
18. Pachler J, Wille-Jorgensen P. Quality of life after rectal resection for cancer, with or without permanent colostomy. Cochrane Database Syst Rev. 2005(2):): Cd004323.http://dx.doi.org/10.1002/14651858.CD004323.pub3.
crossref
19. Edge S, Byrd DR, Compton CC, Fritz AG, Greene FL, Trotti A. AJCC Cancer staging manual. 7th ed.Chicago: Springer science;2011.
20. Zigmond AS, Snaith RP. The hospital anxiety and depression scale. Acta Psychiatr Scand. 1983; 67(6):361–70.
crossref
21. Oh SM, MinK J, Park DB. Astudyonthe standardization of the hospital anxiety and depression scale for Koreans: a comparison of normal, depressedandanxious groups. JKoreanNeuropsychiatr Assoc. 1999; 38(2):289–96.
22. Emmertsen KJ, Laurberg S. Low anterior resection syndrome score: development and validation of a symptom-based scoring system for bowel dysfunction after low anterior resection for rectal cancer. Ann Surg. 2012; 255(5):922–8. http://dx.doi.org/10.1097/SLA.0b013e31824f1c21.
23. Juul T, Ahlberg M, Biondo S, EmmertsenKJ, Espin E, Jimenez LM, et al. Internationalvalidationof the lowanterior resection syndrome score. Ann Surg. 2014; 259(4):728–34. http://dx.doi.org/10.1097/SLA.0b013e31828fac0b.
24. Emmertsen KJ, Laurberg S, Rectal Cancer Function Study G. Impact of bowel dysfunction on quality of life after sphincter-preserving resection for rectal cancer. Br J Surg. 2013; 100(10):1377–87. http://dx.doi.org/10.1002/bjs.9223.
crossref
25. Chen TY, Emmertsen KJ, Laurberg S.Bowel dysfunction after rectal cancertreatment: a studycomparing thespecialist'sver-sus patient's perspective. BMJ Open. 2014; 4(1):): e003374.http://dx.doi.org/10.1136/bmjopen-2013–003374.
26. Lee JH. Quality of life for the gastric cancer patients after gastrectomy; reliability and validity study of the Korean version for the EORTC QLQ C-30 and gastric cancer module. Seoul: Yonsei University Graduate School;2003.
27. Bossema ER, Seuntiens MW, Marijnen CA, Baas-Thijssen MC, van de Velde CJ, Stiggelbout AM. The relation betweenillness cognitionsand qualityof lifeinpeople withandwithout asto-ma following rectal cancer treatment. Psychooncology. 2011; 20(4):428–34. http://dx.doi.org/10.1002/pon.1758.
28. Lim SM. The relationships among bowel function, health locus of control, anxiety and depression in patient with rectal cancer [master's thesis]. Seoul: Ewha University;2013.
29. Baek YA. The correlation among symptoms, anxiety, depression and quality of life in patients with colorectal cancer undergoing chemotherapy [master's thesis]. Seoul: Seoul national University;2013.
30. Min HS, Kim JY. Health-related quality of life of patients with rectal cancer. J Korean Soc Coloproctol. 2009; 25(2):100–6. http://dx.doi.org/10.3393/jksc.2009.25.2.100.
crossref

Table 1.
General Characteristics of the Participants (N=105)
Characteristics Categories n (%)
Age (year) 40 < 1 (1.0)
  40∼49 17 (16.2)
  50∼59 46 (43.8)
  60∼69 29 (27.6)
  70 ≥ 12 (11.4)
Gender Male 70 (66.7)
  Female 35 (33.3)
Level of education None 3 (2.9)
  Elementary school 5 (4.8)
  Middle school 16 (15.2)
  High school 42 (40.0)
  Above college 39 (37.1)
Marital status Married 100 (95.2)
  Divorce 1 (1.0)
  Separation Separation by deat h 2 (1.9) 2 (1.9)
Current main caregiver No (self) 7 (6.7)
  Spouse 95 (90.5)
  Children 3 (2.9)
Religion No 55 (52.4)
  Protestant 23 (21.9)
  Catholic Buddhist 13 (12.4) 14 (13.3)
Over 4 kg weight No 101 (96.2)
loss for 1month Yes 4 (3.8)
Monthly Income 100 < 18 (17.1)
(10,000 won) 100∼199 24 (22.9)
  200∼299 38 (36.2)
  300∼399 400∼499 20 (19.0) 4 (3.8)
  500 ≥ 1 (1.0)
Job Full time job 24 (22.9)
  Part time job 26 (24.8)
  Not have 9 (8.6)
  Housewife 27 (25.7)
Cohabitant Alone Spouse 6 (5.7) 59 (56.2)
  Children 3 (2.9)
  Spouse & children 37 (35.2)
Table 2.
Disease Related Characteristics of the Participants (N=105)
Characteristics Categories n (%) M±SD Min∼Max
LAR operation method Laparotomy 42 (40.0)    
  Laparoscopic operation 62 (59.0)    
  Robot operation 1 (1.0)    
Range of resection TME 99 (94.3)    
  PME 6 (5.7)    
Stage of cancer Stage 1 28 (26.7)    
  2 29 (27.6)    
  3 48 (46.7)    
Neoadjuvant therapy None. Chemotherapy 70 (66.7) 3 (2.9)    
  Radiation 1 (1.0)    
  CCRT (Chemo+Radiation) 31 (29.5)    
Adjuvant therapy None. 41 (39.0)    
  Chemotherapy 47 (44.8)    
  CCRT (Chemo+Radiation) 17 (16.2)    
Temporary ostomy retention No Yes 67 (63.8) 38 (36.2)    
Current treatment None 102 (97.1)    
  Chemotherapy 1 (1.0)    
  CCRT (Chemo+Radiation) 2 (1.9)    
Comorbidity No 80 (76.2)    
  yes 25 (23.8)    
Smoking history No smoker 57 (54.3)    
  Ex-smoker 46 (43.8)    
  Current smoker 2 (1.9)    
Alcohol history No alcoholism 39 (37.1)    
  Ex-alcoholism 53 (50.5)    
  Current alcoholism 13 (12.4)    
Tumor location 0∼5 31 (29.5) 7.72±3.63 1∼15
(distance from AV cm) 6∼10 55 (52.4)    
  11∼15 19 (18.1)    
Transitional period after surgery 4∼11 15 (14.3) 28.42±16.39 4∼59
(month) 12∼23 34 (32.4)    
  24∼35 20 (19.0)    
  36∼47 17 (16.2)    
  48∼59 19 (18.1)    

LAR=low anterior resection; TME=total mesorectal excision; PME=partial mesorectal excision; CCRT=combined chemotherapy and radiation therapy; AV=anal verge.

Table 3.
Descriptive Statistics of the Measured Variables (N=105)
Variables Categories n (%) M±SD Min-Max
Anxiety Normal (0∼7) 99 (94.2) 3.26±2.88 0∼9
  Borderline case (8∼10) 5 (4.8)    
  Probable case (11) ≥ 1 (1.0)    
Depression Normal (0∼7) 95 (90.6) 4.01±2.62 0∼12
  Borderline case (8∼10) 9 (8.6)    
  Probable case (11) ≥ 1 (1.0)    
LARS score No LARS (0∼20) 46 (43.8) 24.22±11.56 0∼41
  Minor LARS (21∼29) 13 (12.4)    
  Major LARS (30∼42) 46 (43.8)    
Quality of life General Health status   68.80±15.15 33∼100
  Functional status   87.12±8.99 56∼100
  Symptom experience   10.31±7.71 0∼30.86
Table 4.
Low Anterior Resection Syndrome Score according to Clinical Characteristics (N=105
Variables Categories n (%) LARS score Scheffé
M±SD F p
Range of excision TME 99 25.17±11.05 12.843 .001  
  PME 6 8.66±8.68      
Tumor location (distance from AV cm) 0∼5a 6∼10b 11∼15c 31 55 19 29.32±11.00 23.80±10.11 17.15±12.86 7.415 .001 a c >
Neoadjuvant therapy Yes 35 29.08±10.10 10.075 .002  
  No 70 21.80±11.54      
Temporary ostomy retention Yes 39 29.97±9.74 17.801 .001 <  
  No 66 20.83±11.26      

TME=total mesorectal excision; PME=partial mesorectal excision; AV=anal verge.

Table 5.
Quality of Life According to Clinical Characteristics (N=105)
Variables Categories n Quality of Life
General health status Functional status Symptom experience
M±SD F (p) M±SD F (p) M±SD F (p)
Range of excision TME PME 99 6 67.92 83.33 ±14.98 ±10.54 6.131 (.015) 86.75 93.16 ±9.02 ±6.16 2.926 (.090) 1 10.58 5.86 ±7.76 ±5.68 2.137 (.147)
Tumor Location (distance from AV; cm) 0∼5a 6∼10b 11∼15c 31 55 19 63.70 68.03 79.38 ±17.15 ±13.49 ±11.23 7.226 (.001) c a, > b 84.64 87.20 90.97 ±10.00 ±8.24 ±8.39 3.008 1 1 12.44 10.16 7.24 ±8.75 ±7.07 ±6.96 2.788 (.066)
Received neoadjuvant Yes 35 61.66 ±15.81 13.005 85.23 ±8.70 2.337 1 14.33 ±7.70 16.418
therapy No 70 72.38 ±13.57 (.001) < 88.06 ±9.04 (.127) 8.29 ±6.94 (.001) <
Temporary ostomy Yes 39 63.88 ±14.97 6.911 83.64 ±9.13 10.119 1 13.72 ±8.06 13.593
retention No 66 71.71 ±14.60 (.010) 89.18 ±8.30 (.002) 8.29 ±6.79 (.001) <

TME=total mesorectal excision; PME=partial mesorectal excision; AV=anal verge; a, b, c=Scheffe test. ́

Table 6.
Correlations among the Measured Variables
Variables LARS score Anxiety Depression Quality of Life
General health status Functional status Symptom experience
Tumor location (distance from AV) ) -.454 (.001) <          
Anxiety .445 (.001) <          
Depression .530 (.001) < .516 (.001 < )      
QOL General health status –.648 (.001) < –.536 (.001 < 1) −652 (.001) <      
Functional status –.612 (.001) < –.616 (.001 < 1) −692 (.001) < .737 (.001) <    
Symptom experience .592 (.001) < .517 (.001 < ) 653 (.001) < –.713 (.001) < –.686 (.001) <  
Table 7.
Variables Predicting Quality of Life
Classification Predicting variables R2 Adjusted R2 R2 change F p
General health status Depression Depression, LARS score Depression, LARS score, anxiety .425 .553 .576 .419 .544 .563 .425 .128 .023 76.093 62.967 45.745 .001 < .001 < .001 <
Functional status Depression Depression, anxiety Depression, Anxiety LARS score .478 .570 .620 .473 .561 .609 .478 .092 .050 94.411 67.500 54.955 .001 < .001 < .001 <
Symptom experience Depression Depression, LARS score Depression, LARS score, anxiety .426 .510 .532 .421 .501 .518 .426 .084 0.22 76.467 53.127 38.213 .001 < .001 < .001 <
TOOLS
Similar articles